Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc. (ALGS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ALGS · as of Jun 9, 2026
Key Statistics
Explore Aligos Therapeutics, Inc. Data
algs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 60.0%
The ALGS analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $20.00, representing +303.23% upside from the current price of $4.96.
Competitors & Peers
algs competitorsALGS
BRNS
CVM
FGEN
INMB
KZRStock Performance
Full HistoryAbout Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for significant unmet medical needs in both viral and liver diseases. Key candidat…
what is aligos therapeutics, inc. · algs stock overview · aligos therapeutics, inc. company profile · who is aligos therapeutics, inc. ceo · algs NASDAQ · aligos therapeutics, inc. headquarters · aligos therapeutics, inc. business segments
About Stock Overview & Key Data
Aligos Therapeutics, Inc. (ALGS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 16, 2020. As of the latest trading session, ALGS stock price is $4.96, with a market capitalization of $30.7M. The stock has returned -31.02% over the past 12 months and -46.78% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Aligos Therapeutics, Inc. stock is Buy, with an average 12-month price target of $20.00. In fiscal year 2025, Aligos Therapeutics, Inc. reported revenue of $2.2M and net income of -$24.2M. For detailed data — including Aligos Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aligos Therapeutics, Inc. (ALGS) stock price is $4.96. The stock is traded on NASDAQ under the ticker symbol ALGS. The 52-week range is $4.80 – $13.69.